FDA delays approval decision for Exelixis' tyrosine kinase inhibitor in colorectal cancer Read more 

The future of RAS inhibitors Read more 

Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'? Read more 

Go to Top